Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence ('AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today provided an update on its strategic licensing partnership with DataVault AI, Inc. (NASDAQ:DVLT), a Pioneer in AI-driven data valuation, monetization, and secure tokenization within Web 3.0 environments.

Through this partnership, Wellgistics has licensed DataVault AI's advanced technology platform to integrate proprietary blockchain-enabled tokenization and blockchain-enabled smart contract capabilities into its patented PharmacyChain™ platform. This enables tokenization of Wellgistics' AI-enabled pharmacy chain - powered by its EinsteinRx™ pharmacy dispensing optimization artificial intelligence - creating secure, immutable digital twins of real-world pharmacy processes, transactions, and assets.

The U.S. prescription drug market, where independent pharmacies play a vital role, represents a $634 billion market opportunity, projected to grow to $883 billion by 2030 according to Grandview Research. This market continues to face significant challenges, including supply chain inefficiencies, lack of transparency, fraud, waste, and delayed payments that strain pharmacy profitability and patient care. The global blockchain in healthcare market currently stands at $11 billion USD, and is projected to grow to $214 billion by 2030 according to Grandview Research, with compound annual rates expected to exceed 60% per year. The size of these two markets expected to be disrupted by EinsteinRx and PharmacyChain underscore the transformative potential that distributed ledger technologies possess to improve traceability, security, and automation in healthcare.

DataVault AI's industry-leading platform, including its patented Information Data Exchange® (IDE) and expertise in securely attaching physical assets to immutable blockchain metadata, provide the foundational intellectual property that enables this tokenization. By leveraging DataVault AI's robust, regulatory-compliant technology, Wellgistics can create tokenized digital representations of pharmacy chain elements - from prescription fulfillment to supply chain provenance - facilitating seamless smart contract execution, real-time data integrity, reduced intermediaries, and new avenues for efficient, trustless transactions across its network of over 6,500 pharmacies.

The companies have successfully completed the feasibility assessment phase and established key milestones toward pilot deployment by year-end 2026:

Complete initial selection of which blockchain platforms are most suitable for the initial deployment of PharmacyChain by the end of the first quarter of 2026;

Establish the 'closed loop' initial HIPAA-compliant data transfers required to close a smart contract-enabled prescription drug transactions (the 'PharmacyChain Contract') via Wellgistics' own pharmacy by the end of the second quarter of 2026;

Successfully close a PharmacyChain Contract via a pilot program with an early adopter pharmacy from among Wellgistics' 6,500 independent pharmacy clients (the 'Wellgistics Pharmacy Network') by the end of the third quarter of 2026;

Begin to expand marketing of PharmacyChain to the entire Wellgistics Pharmacy Network by year-end 2026.

• No comments yet. Be the first to comment!